 | • レポートコード：QYR9ST01005 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の院内感染肺炎予防市場について調査・分析し、以下の構成でお届け致します。院内感染肺炎予防の種類別には、オーラルケアキット、歯ブラシ、スワブ、保湿剤、マウスウォッシュ、吸引ツールに、用途別には、病院、リハビリテーションセンター、在宅ケア設定に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別院内感染肺炎予防売上データ ・地域別院内感染肺炎予防市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別院内感染肺炎予防市場規模：オーラルケアキット、歯ブラシ、スワブ、保湿剤、マウスウォッシュ、吸引ツール ・用途別院内感染肺炎予防市場規模：病院、リハビリテーションセンター、在宅ケア設定 ・主要メーカーの企業情報：Halyard Health、Sage Products LLC、Intersurgical Ltd.、Medline Industries ・院内感染肺炎予防の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcare centers and increases the length of stay in ICU.The global Hospital-Acquired Pneumonia Prevention market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hospital-Acquired Pneumonia Prevention market based on company, product type, end user and key regions.
This report studies the global market size of Hospital-Acquired Pneumonia Prevention in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hospital-Acquired Pneumonia Prevention in these regions.
This research report categorizes the global Hospital-Acquired Pneumonia Prevention market by top players/brands, region, type and end user. This report also studies the global Hospital-Acquired Pneumonia Prevention market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Halyard Health
Sage Products LLC
Intersurgical Ltd.
Medline Industries
Market size by Product
Oral Care Kit
Toothbrush
Swab
Moisturizer
Mouth Wash
Suction Tools
Market size by End User
Hospitals
Rehabilitation Centers
Home Care Settings
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hospital-Acquired Pneumonia Prevention market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hospital-Acquired Pneumonia Prevention market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hospital-Acquired Pneumonia Prevention companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hospital-Acquired Pneumonia Prevention submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hospital-Acquired Pneumonia Prevention are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hospital-Acquired Pneumonia Prevention market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Hospital-Acquired Pneumonia Prevention Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Product
1.4.2 Oral Care Kit
1.4.3 Toothbrush
1.4.4 Swab
1.4.5 Moisturizer
1.4.6 Mouth Wash
1.4.7 Suction Tools
1.5 Market by End User
1.5.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Rehabilitation Centers
1.5.4 Home Care Settings
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hospital-Acquired Pneumonia Prevention Market Size
2.1.1 Global Hospital-Acquired Pneumonia Prevention Revenue 2014-2025
2.1.2 Global Hospital-Acquired Pneumonia Prevention Sales 2014-2025
2.2 Hospital-Acquired Pneumonia Prevention Growth Rate by Regions
2.2.1 Global Hospital-Acquired Pneumonia Prevention Sales by Regions
2.2.2 Global Hospital-Acquired Pneumonia Prevention Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Hospital-Acquired Pneumonia Prevention Sales by Manufacturers
3.1.1 Hospital-Acquired Pneumonia Prevention Sales by Manufacturers
3.1.2 Hospital-Acquired Pneumonia Prevention Sales Market Share by Manufacturers
3.1.3 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio (CR5 and HHI)
3.2 Hospital-Acquired Pneumonia Prevention Revenue by Manufacturers
3.2.1 Hospital-Acquired Pneumonia Prevention Revenue by Manufacturers (2014-2019)
3.2.2 Hospital-Acquired Pneumonia Prevention Revenue Share by Manufacturers (2014-2019)
3.3 Hospital-Acquired Pneumonia Prevention Price by Manufacturers
3.4 Hospital-Acquired Pneumonia Prevention Manufacturing Base Distribution, Product Types
3.4.1 Hospital-Acquired Pneumonia Prevention Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hospital-Acquired Pneumonia Prevention Product Type
3.4.3 Date of International Manufacturers Enter into Hospital-Acquired Pneumonia Prevention Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Hospital-Acquired Pneumonia Prevention Sales by Product
4.2 Global Hospital-Acquired Pneumonia Prevention Revenue by Product
4.3 Hospital-Acquired Pneumonia Prevention Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Hospital-Acquired Pneumonia Prevention Breakdown Data by End User
6 North America
6.1 North America Hospital-Acquired Pneumonia Prevention by Countries
6.1.1 North America Hospital-Acquired Pneumonia Prevention Sales by Countries
6.1.2 North America Hospital-Acquired Pneumonia Prevention Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hospital-Acquired Pneumonia Prevention by Product
6.3 North America Hospital-Acquired Pneumonia Prevention by End User
7 Europe
7.1 Europe Hospital-Acquired Pneumonia Prevention by Countries
7.1.1 Europe Hospital-Acquired Pneumonia Prevention Sales by Countries
7.1.2 Europe Hospital-Acquired Pneumonia Prevention Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hospital-Acquired Pneumonia Prevention by Product
7.3 Europe Hospital-Acquired Pneumonia Prevention by End User
8 Asia Pacific
8.1 Asia Pacific Hospital-Acquired Pneumonia Prevention by Countries
8.1.1 Asia Pacific Hospital-Acquired Pneumonia Prevention Sales by Countries
8.1.2 Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hospital-Acquired Pneumonia Prevention by Product
8.3 Asia Pacific Hospital-Acquired Pneumonia Prevention by End User
9 Central & South America
9.1 Central & South America Hospital-Acquired Pneumonia Prevention by Countries
9.1.1 Central & South America Hospital-Acquired Pneumonia Prevention Sales by Countries
9.1.2 Central & South America Hospital-Acquired Pneumonia Prevention Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hospital-Acquired Pneumonia Prevention by Product
9.3 Central & South America Hospital-Acquired Pneumonia Prevention by End User
10 Middle East and Africa
10.1 Middle East and Africa Hospital-Acquired Pneumonia Prevention by Countries
10.1.1 Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales by Countries
10.1.2 Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hospital-Acquired Pneumonia Prevention by Product
10.3 Middle East and Africa Hospital-Acquired Pneumonia Prevention by End User
11 Company Profiles
11.1 Halyard Health
11.1.1 Halyard Health Company Details
11.1.2 Company Business Overview
11.1.3 Halyard Health Hospital-Acquired Pneumonia Prevention Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Halyard Health Hospital-Acquired Pneumonia Prevention Products Offered
11.1.5 Halyard Health Recent Development
11.2 Sage Products LLC
11.2.1 Sage Products LLC Company Details
11.2.2 Company Business Overview
11.2.3 Sage Products LLC Hospital-Acquired Pneumonia Prevention Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sage Products LLC Hospital-Acquired Pneumonia Prevention Products Offered
11.2.5 Sage Products LLC Recent Development
11.3 Intersurgical Ltd.
11.3.1 Intersurgical Ltd. Company Details
11.3.2 Company Business Overview
11.3.3 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Products Offered
11.3.5 Intersurgical Ltd. Recent Development
11.4 Medline Industries
11.4.1 Medline Industries Company Details
11.4.2 Company Business Overview
11.4.3 Medline Industries Hospital-Acquired Pneumonia Prevention Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Medline Industries Hospital-Acquired Pneumonia Prevention Products Offered
11.4.5 Medline Industries Recent Development
12 Future Forecast
12.1 Hospital-Acquired Pneumonia Prevention Market Forecast by Regions
12.1.1 Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Regions 2019-2025
12.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue Forecast by Regions 2019-2025
12.2 Hospital-Acquired Pneumonia Prevention Market Forecast by Product
12.2.1 Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Product 2019-2025
12.2.2 Global Hospital-Acquired Pneumonia Prevention Revenue Forecast by Product 2019-2025
12.3 Hospital-Acquired Pneumonia Prevention Market Forecast by End User
12.4 North America Hospital-Acquired Pneumonia Prevention Forecast
12.5 Europe Hospital-Acquired Pneumonia Prevention Forecast
12.6 Asia Pacific Hospital-Acquired Pneumonia Prevention Forecast
12.7 Central & South America Hospital-Acquired Pneumonia Prevention Forecast
12.8 Middle East and Africa Hospital-Acquired Pneumonia Prevention Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hospital-Acquired Pneumonia Prevention Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Hospital-Acquired Pneumonia Prevention Product Picture
Table Hospital-Acquired Pneumonia Prevention Market Segments
Table Key Manufacturers Hospital-Acquired Pneumonia Prevention Covered
Table Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Product 2014-2025
Figure Oral Care Kit Product Picture
Table Major Manufacturers of Oral Care Kit
Figure Toothbrush Product Picture
Table Major Manufacturers of Toothbrush
Figure Swab Product Picture
Table Major Manufacturers of Swab
Figure Moisturizer Product Picture
Table Major Manufacturers of Moisturizer
Figure Mouth Wash Product Picture
Table Major Manufacturers of Mouth Wash
Figure Suction Tools Product Picture
Table Major Manufacturers of Suction Tools
Table Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Rehabilitation Centers
Figure Home Care Settings
Figure Hospital-Acquired Pneumonia Prevention Report Years Considered
Figure Global Hospital-Acquired Pneumonia Prevention Market Size 2014-2025 (Million US$)
Figure Global Hospital-Acquired Pneumonia Prevention Sales 2014-2025 (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Hospital-Acquired Pneumonia Prevention Sales by Regions 2014-2019 (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Regions 2014-2019
Figure Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Regions 2014-2019
Figure 2018 Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Regions
Table Global Hospital-Acquired Pneumonia Prevention Revenue by Regions 2014-2019 (Million US$)
Table Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Regions 2014-2019
Figure Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Regions 2014-2019
Figure 2018 Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Regions
Table Global Hospital-Acquired Pneumonia Prevention Sales by Manufacturers (2014-2019) (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Share by Manufacturers (2014-2019)
Figure Global Hospital-Acquired Pneumonia Prevention Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hospital-Acquired Pneumonia Prevention Revenue by Manufacturers (2014-2019) (Million USD)
Table Hospital-Acquired Pneumonia Prevention Revenue Share by Manufacturers (2014-2019)
Figure Hospital-Acquired Pneumonia Prevention Value Share by Manufacturers in 2018
Table Key Manufacturers Hospital-Acquired Pneumonia Prevention Price (2014-2019) (USD/Unit)
Table Hospital-Acquired Pneumonia Prevention Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hospital-Acquired Pneumonia Prevention Product Type
Table Date of International Manufacturers Enter into Hospital-Acquired Pneumonia Prevention Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Share by Product (2014-2019)
Figure Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Product in 2018
Table Global Hospital-Acquired Pneumonia Prevention Revenue by Product (2014-2019) (Million US$)
Table Global Hospital-Acquired Pneumonia Prevention Revenue Share by Product (2014-2019)
Figure Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Product (2014-2019)
Figure Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Product in 2018
Table Hospital-Acquired Pneumonia Prevention Price by Product 2014-2019 (USD/Unit)
Table Global Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Share by End User (2014-2019)
Figure Global Sales Hospital-Acquired Pneumonia Prevention Market Share by End User (2014-2019)
Figure Global Sales Hospital-Acquired Pneumonia Prevention Market Share by End User in 2018
Figure North America Hospital-Acquired Pneumonia Prevention Sales Growth Rate 2014-2019 (K Units)
Figure North America Hospital-Acquired Pneumonia Prevention Revenue Growth Rate 2014-2019 (Million US$)
Table North America Hospital-Acquired Pneumonia Prevention Sales by Countries (2014-2019) (K Units)
Table North America Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries (2014-2019)
Figure 2018 North America Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries
Table North America Hospital-Acquired Pneumonia Prevention Revenue by Countries (2014-2019) (Million US$)
Table North America Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries
Figure United States Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure United States Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Canada Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Table North America Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table North America Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure 2018 North America Hospital-Acquired Pneumonia Prevention Market Share by Product
Table North America Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table North America Hospital-Acquired Pneumonia Prevention Sales Market Share by End User (2014-2019)
Figure 2018 North America Hospital-Acquired Pneumonia Prevention Market Share by End User
Figure Europe Hospital-Acquired Pneumonia Prevention Sales Growth Rate 2014-2019 (K Units)
Figure Europe Hospital-Acquired Pneumonia Prevention Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Hospital-Acquired Pneumonia Prevention Sales by Countries (2014-2019) (K Units)
Table Europe Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries
Table Europe Hospital-Acquired Pneumonia Prevention Revenue by Countries (2014-2019) (Million US$)
Table Europe Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries
Figure Germany Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Germany Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure France Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure France Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure UK Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Italy Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Russia Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table Europe Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure 2018 Europe Hospital-Acquired Pneumonia Prevention Market Share by Product
Table Europe Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table Europe Hospital-Acquired Pneumonia Prevention Sales Market Share by End User (2014-2019)
Figure 2018 Europe Hospital-Acquired Pneumonia Prevention Market Share by End User
Figure Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries
Figure China Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure China Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Japan Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Korea Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure India Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure India Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Australia Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Hospital-Acquired Pneumonia Prevention Market Share by Product
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Hospital-Acquired Pneumonia Prevention Market Share by End User
Figure Central & South America Hospital-Acquired Pneumonia Prevention Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Hospital-Acquired Pneumonia Prevention Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales by Countries (2014-2019) (K Units)
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries
Table Central & South America Hospital-Acquired Pneumonia Prevention Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries
Figure Brazil Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Hospital-Acquired Pneumonia Prevention Market Share by Product
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table Central & South America Hospital-Acquired Pneumonia Prevention Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Hospital-Acquired Pneumonia Prevention Market Share by End User
Figure Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Market Share by Countries
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue Market Share by Countries
Figure GCC Countries Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Hospital-Acquired Pneumonia Prevention Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Hospital-Acquired Pneumonia Prevention Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Hospital-Acquired Pneumonia Prevention Market Share by Product
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Hospital-Acquired Pneumonia Prevention Market Share by End User
Table Halyard Health Company Details
Table Halyard Health Hospital-Acquired Pneumonia Prevention Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Halyard Health Recent Development
Table Sage Products LLC Company Details
Table Sage Products LLC Hospital-Acquired Pneumonia Prevention Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sage Products LLC Recent Development
Table Intersurgical Ltd. Company Details
Table Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intersurgical Ltd. Recent Development
Table Medline Industries Company Details
Table Medline Industries Hospital-Acquired Pneumonia Prevention Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medline Industries Recent Development
Table Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Regions 2019-2025 (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Market Share Forecast by Regions 2019-2025
Table Global Hospital-Acquired Pneumonia Prevention Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Hospital-Acquired Pneumonia Prevention Revenue Market Share Forecast by Regions 2019-2025
Table Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Product 2019-2025 (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Market Share Forecast by Product 2019-2025
Table Global Hospital-Acquired Pneumonia Prevention Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Hospital-Acquired Pneumonia Prevention Revenue Market Share Forecast by Product 2019-2025
Table Global Hospital-Acquired Pneumonia Prevention Sales Forecast by End User 2019-2025 (K Units)
Table Global Hospital-Acquired Pneumonia Prevention Sales Market Share Forecast by End User 2019-2025
Figure North America Hospital-Acquired Pneumonia Prevention Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Hospital-Acquired Pneumonia Prevention Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Hospital-Acquired Pneumonia Prevention Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Hospital-Acquired Pneumonia Prevention Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Hospital-Acquired Pneumonia Prevention Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Hospital-Acquired Pneumonia Prevention Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Hospital-Acquired Pneumonia Prevention Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Hospital-Acquired Pneumonia Prevention Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Hospital-Acquired Pneumonia Prevention Value Chain
Table Hospital-Acquired Pneumonia Prevention Customers List
Table Hospital-Acquired Pneumonia Prevention Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の院内感染肺炎薬パイプライン分析市場：専門的調査 Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being mu…- 院内感染（HAI）診断の世界市場：市場規模・現状・予測 Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populatio…
- 院内感染制御の世界市場：市場規模・現状・予測 A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection…
- 院内尿路感染症の世界市場：インサイト・予測 Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.They are accountable for over 50% of infections. …
- 院内感染治療の世界市場：市場規模・現状・予測 Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. In 2018, the global Hospital Acquired Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2…